Insider Shareholders with Direct Ownership of Cv Rx, Inc. (CVRX)
This section provides a comprehensive overview of the insiders with direct ownership of Cv Rx, Inc. (CVRX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
CVRx, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Enterprise Associates 10 L P New
> 10% Shareholder |
2,026,083 | 0 | 2,026,083 $29.9 Million | 1 |
Jul 02, 2021
Added 10.02%
|
|
Dean Bruhn Ding
VP OF REG. AFFAIRS AND QA |
49,000 | 0 | 54,648 $807,150 | 2 |
Feb 08, 2022
Added 8.62%
|
| 30,645 | 0 | 30,645 $452,626 | 7 |
Aug 15, 2024
Added 8.92%
|
|
|
Kevin Hykes
PRES & CEO |
30,000 | 0 | 30,000 $443,100 | 1 |
Aug 05, 2024
Added 50.0%
|
| 27,777 | 0 | 28,266 $417,488 | 1 |
Jul 02, 2021
Added 49.56%
|
|
|
Nadim Yared
CHIEF EXECUTIVE OFFICER |
43,835 | 17,580 | 26,255 $387,786 | 7 |
Jan 29, 2024
Added 6.9%
|
|
John Brintnall
CHIEF STRATEGY OFFICER AND SEC |
21,901 | 0 | 21,901 $323,477 | 3 |
Apr 22, 2022
Added 5.46%
|
|
Jared Oasheim
CHIEF FINANCIAL OFFICER |
15,447 | 0 | 15,447 $228,152 | 2 |
Sep 18, 2023
Added 25.67%
|
| 3,400 | 0 | 3,400 $50,218 | 5 |
Feb 28, 2022
Added 15.0%
|
|
|
Craig E. Palmer
SVP, U.S. SALES |
1,229 | 0 | 1,229 $18,152 | 2 |
Mar 25, 2024
Added 10.94%
|
|
Paul Verrastro
CHIEF MKTG & STRAT OFFICER |
20,250 | 19,415 | 835 $12,332 | 13 |
Nov 21, 2024
Reduced 55.47%
|
|
Liz Galle
VP OF GLOBAL CLINICAL RESEARCH |
778 | 0 | 778 $11,491 | 1 |
Oct 16, 2023
Added 50.0%
|
| 316 | 0 | 316 $4,667 | 1 |
Dec 14, 2023
Added 50.0%
|
|
|
Johnson & Johnson Innovation Jjdc, Inc.
> 10% Shareholder |
0 | 3,495,575 | 0 $0 | 1 |
Sep 15, 2023
Reduced 100.0%
|